TE HANGARAU WHAKAMUTUNGA O BEIJING INC.

Kua tukuna te tuawhā o ngā tuhinga whakaae nui, i arahina e te Komiti Thrombosis me te Hemostasis o te Rōpū Hainamana o ngā Hōhipera Rangahau.

I whakawhanakehia ngātahitia te "Whakaaetanga Tohunga mō te Aroturukitanga Hauora o ngā Rongoā Heparin" e te Komiti Thrombosis me te Hemostasis o te Rōpū Haina o ngā Hōhipera Rangahau me te Peka Pūtaiao Taiwhanga o te Rōpū Karakia Hainamana. E rua tau te roa o te whakawhanaketanga o tēnei tuhinga, i tuhia ngātahitia e ngā tohunga maha-mātauranga puta noa i Haina, whai muri i ngā kōrero me ngā whakatikatika maha. I whakaaetia te tauira whakamutunga, ā, i whakaputaina i te marama o Ākuhata 2025 i roto i te Chinese Journal of Laboratory Medicine, Pukapuka 48, Putanga 8.

Mā tēnei whakaaetanga ka whakaratohia he aratohu paerewa mō te aroturuki taiwhanga o ngā rongoā rite ki te heparin, e tuku ana i te tautoko taiwhanga pono ake mō te whakatinanatanga haumaru me te whai hua o te rongoā ārai toto haumanu. Hei whakamutunga, ka whai hua te whānuitanga o ngā tūroro, ā, ka pai ake te paerewa me te tika o te rongoā ārai toto heparin.

WHAKARĀPOPOTONGA

Ko ngā rongoā rite ki te Heparin he rongoā ārai toto e whakamahia whānuitia ana hei ārai me te rongoā i ngā mate thromboembolic. He mea nui te whakamahinga tika me te aroturuki tika i ēnei rongoā hei whakarite i te haumaru me te whai huatanga o te maimoatanga. I ahu mai tēnei whakaae a ngā tohunga i ngā tuhinga ā-rohe me ā-ao e tika ana, me te whakaaro katoa ki te āhua me te ahunga whakamua o te whakamahinga heparin i tēnei wā. I huihuia he rōpū tohunga i roto i te mara antithrombotic, tae atu ki ngā tohunga taiwhanga me ngā tohunga haumanu, hei matapaki i ngā tohu, te horopeta, me te aroturukitanga o te heparin. Ina koa, i whakamāramahia te whakamahinga haumanu o ngā tohu taiwhanga pēnei i te mahi anti-Xa me te whakatakoto i ngā taunakitanga a ngā tohunga me te whāinga ki te whakatairanga i te whakamahinga haumaru me te whai hua o te heparin me te whakataurite i te aroturuki taiwhanga.He tuhinga anō tēnei nō: Thrombosis and Hemostasis (CSTH).

Kua roa a Beijing Succeeder Technology Inc. (waehere hea: 688338) e whai wāhi nui ana ki te mara o te tātaritanga toto toto mai i tōna whakatūnga i te tau 2003, ā, e whakapau kaha ana ki te noho hei kaiārahi i tēnei mara. Kei Beijing te tari matua, ā, he kaha te tīma R&D, whakaputa me te hoko a te kamupene, e arotahi ana ki te auahatanga me te whakamahi i te hangarau tātaritanga toto toto me te hemostasis.

Nā tōna kaha hangarau tino pai, kua toa a Succeeder i ngā mana pateni whai mana e 45, tae atu ki ngā mana pateni hanga hou e 14, ngā mana pateni tauira whaipainga e 16 me ngā mana pateni hoahoa e 15. E 32 hoki ngā tiwhikete rēhita hua taputapu hauora Akomanga II a te kamupene, e 3 ngā tiwhikete tuku Akomanga I, me te tiwhikete EU CE mō ngā hua e 14, ā, kua paahitia e ia te tiwhikete pūnaha whakahaere kounga ISO 13485 hei whakarite i te hiranga me te pumau o te kounga hua.

Ehara i te mea ko Succeeder anake te hinonga matua o te Beijing Biomedicine Industry Leapfrog Development Project (G20), engari i angitu hoki tana whakaurunga ki te Science and Technology Innovation Board i te tau 2020, ā, i eke ki te whanaketanga tere o te kamupene. I tēnei wā, kua hangaia e te kamupene he whatunga hokohoko ā-motu e kapi ana i ngā rau o ngā kaihoko me ngā tari. He pai te hoko o ana hua i te nuinga o ngā wāhi o te whenua. Kei te kaha hoki tana whakawhānui i ngā mākete o tāwāhi, me te whakapai tonu i tana whakataetae ā-ao.